8-K: Vicarious Surgical Files for Dissolution and Asset Assignment
Current Report (8-K) Assignment for Benefit of Creditors and Dissolution
Vicarious Surgical Inc. has filed a Form 8-K announcing the approval of a general assignment for the benefit of creditors and a plan of dissolution, leading to the resignation of its board and termination of key executives.
Summary
- Vicarious Surgical Inc. (the Company) has entered into a General Assignment for the Benefit of Creditors with Vicarious Liquidation, LLC.
- This action involves the transfer of substantially all of the Company's assets to the Assignee.
- Stockholders approved the assignment for the benefit of creditors and a voluntary dissolution and liquidation plan.
- The Company's Board of Directors and key executives, including the CEO, President, CTO, and CMO, have resigned or been terminated.
- The Company intends to deregister its common stock and file a Certificate of Dissolution.
- Creditors are expected to have priority over stockholders in asset distributions; stockholders are unlikely to receive any distribution.
- The Company's stock registration under the Securities Exchange Act of 1934 will be terminated.
- The effective date for the termination of stock registration is expected to be approximately 90 days after filing Form 15.
Sentiment
Score: 1
Explanation: StockSavvy.ai views this filing as extremely negative, signaling the complete cessation of business operations and the likely loss of all shareholder value.
Negatives
- The company is unable to pay its debts in full.
- Stockholders are not expected to receive any distribution from the assigned assets after creditors are satisfied.
- All members of the Board of Directors have resigned.
- Key executive officers (CEO, President, CTO, CMO) have been terminated.
- The company is undergoing voluntary dissolution and liquidation.
Risks
- Stockholders are unlikely to recover any investment as creditors will be prioritized in asset distribution.
- The company's business operations will cease.
- The company's common stock will be deregistered, impacting liquidity and future trading.
- The extent to which severance payments are ultimately made will be determined in connection with the Assignment and applicable law.
Future Outlook
The company is undergoing voluntary dissolution and liquidation. Its common stock registration will be terminated, and it intends to file for dissolution, with deregistration expected to become effective approximately 90 days after filing Form 15.
Management Comments
- The Board determined that the transfer of substantially all assets through an assignment for the benefit of creditors was in the best interests of the Company.
- The Board determined that the dissolution and liquidation was in the best interests of the Company.
- The resignations of the Board members were not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
Industry Context
StockSavvy.ai notes that this filing indicates a complete cessation of operations for Vicarious Surgical Inc., a move often seen when a company is unable to meet its financial obligations or achieve its strategic objectives, leading to asset liquidation and dissolution.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Board Member | Joseph Doherty | Upon filing of Form 15 | Resignation | |
| Board Member | Stephen From | Upon filing of Form 15 | Resignation | |
| Board Member | Adam Sachs | Upon filing of Form 15 | Resignation | |
| Board Member | Sammy Khalifa | Upon filing of Form 15 | Resignation | |
| Board Member | David Ho | Upon filing of Form 15 | Resignation | |
| Board Member | Victoria Carr-Brendel | Upon filing of Form 15 | Resignation | |
| Board Member | Fuad Ahmad | Upon filing of Form 15 | Resignation | |
| Chief Executive Officer | Stephen From | 2026-07-21 | Termination in connection with Assignment | |
| President | Adam Sachs | 2026-07-21 | Termination in connection with Assignment | |
| Chief Technology Officer | Sammy Khalifa | 2026-07-21 | Termination in connection with Assignment | |
| Chief Medical Officer | Dr. Barry Greene | 2026-07-21 | Termination in connection with Assignment |
Stakeholder Impact
- Shareholders: Expected to receive no distribution from asset liquidation, indicating a total loss of investment.
- Creditors: Will have priority in receiving distributions from the assigned assets.
- Employees: Employment has been terminated for key executives; the impact on other employees is not detailed but likely negative given the dissolution.
- Suppliers: May not be fully compensated if asset liquidation is insufficient to cover all liabilities.
Next Steps
- File Form 15 with the SEC to voluntarily deregister common stock.
- File a Certificate of Dissolution with the Delaware Secretary of State.
- The Assignee will administer and liquidate the assigned assets for the benefit of creditors.
- Deregistration of common stock is expected to become effective approximately 90 days after filing Form 15.
Key Dates
| Date | Description |
|---|---|
| 2026-06-10 | Record Date for determining stockholders entitled to vote at the Special Meeting. |
| 2026-06-22 | Date of filing of the Company's definitive proxy statement for the Special Meeting. |
| 2026-07-21 | Date of the Special Meeting of Stockholders; Board determination for assignment and dissolution; Entry into Assignment Agreement; Termination of executive employment; Board resignations effective upon Form 15 filing; Company intends to file Form 15 for deregistration; Company intends to file Certificate of Dissolution. |
| 2026-07-22 | Approximate date the Company intends to file a Certificate of Dissolution with the Delaware Secretary of State. |
Recommendation
sellThe company is undergoing a complete dissolution and liquidation process, with no expectation of recovery for shareholders. This filing signals the end of the company as an operating entity and a total loss for investors.
Keywords
Vicarious Surgical, 8-K Filing, Assignment for Benefit of Creditors, Dissolution, Liquidation, Deregistration, Asset Transfer, Executive Resignation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.